View in EDS

Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial.

Saved in:
Bibliographic Details
Title: Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial.
Authors: Mhlanga FG; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe. Electronic address: fmhlanga@uz-ctrc.org., Szydlo DW; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, WA, USA., Mayo AJ; FHI 360, Durham, NC, USA., Bunge K; University of Pittsburgh and the Magee-Womens Research Institute, Pittsburgh, PA, USA., Fairlie L; Maternal and Child Health, Wits Reproductive Health and HIV Institute, Johannesburg, South Africa., Nakabiito C; Makerere University-Johns Hopkins University, Kampala, Uganda., Musara P; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Mgodi NM; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Dadabhai S; Johns Hopkins Research Project-Kamuzu University of Health Sciences, Blantyre, Malawi., Scheckter R; FHI 360, Durham, NC, USA., Anderson PL; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Marzinke MA; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Chappell C; University of Pittsburgh and the Magee-Womens Research Institute, Pittsburgh, PA, USA., Gadama LA; Johns Hopkins Research Project-Kamuzu University of Health Sciences, Blantyre, Malawi., Richardson BA; Department of Biostatistics and Department of Global Health, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Piper JM; DAIDS/NIAID/NIH/HHS, Rockville, ML, USA., Hillier SL; University of Pittsburgh and the Magee-Womens Research Institute, Pittsburgh, PA, USA.
Corporate Authors: MTN-042 DELIVER study team
Source: The lancet. HIV [Lancet HIV] 2026 Mar; Vol. 13 (3), pp. e176-e184. Date of Electronic Publication: 2026 Feb 10.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41687672
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mhlanga+FG%22">Mhlanga FG</searchLink>; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe. Electronic address: fmhlanga@uz-ctrc.org.<br /><searchLink fieldCode="AU" term="%22Szydlo+DW%22">Szydlo DW</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Mayo+AJ%22">Mayo AJ</searchLink>; FHI 360, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Bunge+K%22">Bunge K</searchLink>; University of Pittsburgh and the Magee-Womens Research Institute, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Fairlie+L%22">Fairlie L</searchLink>; Maternal and Child Health, Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Nakabiito+C%22">Nakabiito C</searchLink>; Makerere University-Johns Hopkins University, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Musara+P%22">Musara P</searchLink>; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.<br /><searchLink fieldCode="AU" term="%22Mgodi+NM%22">Mgodi NM</searchLink>; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.<br /><searchLink fieldCode="AU" term="%22Dadabhai+S%22">Dadabhai S</searchLink>; Johns Hopkins Research Project-Kamuzu University of Health Sciences, Blantyre, Malawi.<br /><searchLink fieldCode="AU" term="%22Scheckter+R%22">Scheckter R</searchLink>; FHI 360, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+PL%22">Anderson PL</searchLink>; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Marzinke+MA%22">Marzinke MA</searchLink>; Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Chappell+C%22">Chappell C</searchLink>; University of Pittsburgh and the Magee-Womens Research Institute, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Gadama+LA%22">Gadama LA</searchLink>; Johns Hopkins Research Project-Kamuzu University of Health Sciences, Blantyre, Malawi.<br /><searchLink fieldCode="AU" term="%22Richardson+BA%22">Richardson BA</searchLink>; Department of Biostatistics and Department of Global Health, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Piper+JM%22">Piper JM</searchLink>; DAIDS/NIAID/NIH/HHS, Rockville, ML, USA.<br /><searchLink fieldCode="AU" term="%22Hillier+SL%22">Hillier SL</searchLink>; University of Pittsburgh and the Magee-Womens Research Institute, Pittsburgh, PA, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22MTN-042+DELIVER+study+team%22">MTN-042 DELIVER study team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101645355%22">The lancet. HIV</searchLink> [Lancet HIV] 2026 Mar; Vol. 13 (3), pp. e176-e184. <i>Date of Electronic Publication: </i>2026 Feb 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101645355 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3018 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523018%22">23523018 </searchLink><i>NLM ISO Abbreviation: </i>Lancet HIV <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41687672
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2352-3018(25)00307-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e176
    Titles:
      – TitleFull: Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mhlanga FG
      – PersonEntity:
          Name:
            NameFull: Szydlo DW
      – PersonEntity:
          Name:
            NameFull: Mayo AJ
      – PersonEntity:
          Name:
            NameFull: Bunge K
      – PersonEntity:
          Name:
            NameFull: Fairlie L
      – PersonEntity:
          Name:
            NameFull: Nakabiito C
      – PersonEntity:
          Name:
            NameFull: Musara P
      – PersonEntity:
          Name:
            NameFull: Mgodi NM
      – PersonEntity:
          Name:
            NameFull: Dadabhai S
      – PersonEntity:
          Name:
            NameFull: Scheckter R
      – PersonEntity:
          Name:
            NameFull: Anderson PL
      – PersonEntity:
          Name:
            NameFull: Marzinke MA
      – PersonEntity:
          Name:
            NameFull: Chappell C
      – PersonEntity:
          Name:
            NameFull: Gadama LA
      – PersonEntity:
          Name:
            NameFull: Richardson BA
      – PersonEntity:
          Name:
            NameFull: Piper JM
      – PersonEntity:
          Name:
            NameFull: Hillier SL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2352-3018
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The lancet. HIV
              Type: main
ResultId 1